Management and Board

Management

Sabine Bois

Sabine Bois - CEO

Sabine Bois, CEO of the Occlutech Group, has an MBA in Entrepreneurship and Finance. She has over 15 years’ experience in the Biotech/Med-tech industry. She supported the foundation of several successful start-ups and co-founded a biotech company in 2007. After selling the company in 2013 she joined Occlutech in 2014 as CFO and was appointed as Co-CEO in 2017.

Lars Wadell

Lars Wadell - CFO

Lars Wadell graduated with a degree in Finance and International Business from the Stockholm School of Economics. He has extensive experience in financial leadership within  rapidly-expanding international and multicultural organizations within the Life Science, Healthcare & Care, and IT industries. Before joining Occlutech, he served as CFO at TFS Trial Form Support International AB. Prior experience includes being Deputy CEO and CFO at Svar Life Science, CFO at Ambea AB, and Group Controller at Intentia AB (publ). He joined Occlutech in 2021.

Oshri Budana - Global Head of Operations

Oshri Budana holds a Bachelor’s in Business/Managerial Economics. He has extensive international business development expertise and more than 20 years’ experience in building and managing cross-functional teams and companies in different industries. He joined Occlutech in 2019.

Stefan Kleidon - VP Sales & Marketing

Stefan Kleidon graduated from Kassel  University as Economist for Marketing and Business incorporation. He has worked for 20 years in Sales & Marketing in the Med-tech Industry and held various management positions at global players as well as start-up companies. He has a track record of successful business development and market access projects, in which he successfully launched new therapy options.  He joined Occlutech in June 2014.

Board

Marianne Dicander Alexandersson

Marianne Dicander Alexandersson

Chairman of the Board

Intro / Experience:
Marianne Dicander Alexandersson is a Swedish national with a broad business and leadership experience. She has many years of experience in the life science industry and from board work, including as CEO of Kronans Droghandel, Global Health Partner and the Sixth AP Fund, deputy CEO of Apoteket AB, and positions within quality and market development at Pharmacia, Imperial Chemical Industries and Volvo.

Board member since: 2021

Current assignments:
Chairman of the Board of Saminvest AB
Sahlgrenska Science Park AB
The Royal Swedish Academy of Engineering Sciences (IVA Väst)
Board member of Linc AB and Promore Pharma AB
Member of the Advisory Council of the Dental and Pharmaceutical Agency, TLV

Education:
M.Sc. in Chemical Engineering from Chalmers University of Technology.

Holdings in the company:

Independent in relation to the company/major shareholders: Yes/Yes

Urs Christen

Urs Christen

Member of the Board

Intro / Experience:
Urs Christen is a Swiss national and is the founder, owner and CEO of the medical trading company Fumedica, which focuses on Interventional Cardiology, Structural Heart, Heart Surgery & General Surgery and has activities in Germany and Switzerland. He has extensive experience as chairman of the board of directors and as shareholder of various international companies in the above-mentioned fields such as Jotec GmbH (sold to Cryolife in 2018) and New Valve Technology (acquired by Biosensors/Bluesail in 2020).

Board member since: 2020

Current assignments:
CEO & Chairman of the Board of Fumedica Switzerland & Germany
CEO & Chairman of the Board of Medira AG, Muri
Chairman of the Board of Valtronic Technologies SA, Charbonnières
Member of the Board of AcivCell Group AG, Mosen
Member of the Board & Vice President of Hotel Muri AG, Muri

Education:
Laboratory chemist

Holdings in the company:
290,376 shares

Independent in relation to the company/major shareholders: No/Yes

Mette-Marie Harild

Mette-Marie Harild

Member of the Board

Intro/Experience:
Mette-Marie Harild is a Danish national and a medical device industry veteran who has worked in the pharma/medical industry for more than thirty years. She has previously held sales and marketing positions at Rhone Poulenc and Janssen Pharma. She has also served as the Regional Vice President Medtronic A/S in different regions for 13 years.

Board member since: 2021

Board experience:
AmCham Healthcare Committee, Chairman (2016-2021)
Danish Chamber of Commerce, Board Member (2018-2021)
Danish Chamber of Commerce, Chairman of Life Science Board (2018-2021)
Danish Business Development Board under the Ministry of Commerce (Dansk Erhvervsfremmebestyrelse) (2019-2021)
Neurescue, Board member (2021-)
Q life, to be decided at AGMs in May

Education:
Executive board education CBS
Executive MBA in Change Management from Århus School of Business and University, Southern Denmark
Wharton University executive education (advanced leader)
Medif – Mefa examination
Educated Dentist from Copenhagen Dentist School
Several Management, Marketing and Sales Management courses

Holdings in the company:

Independent in relation to the company/major shareholders: Yes/Yes

Helena Levander

Helena Levander

Member of the Board

Intro / Experience:
Helena Levander is a Swedish national and a board professional with 20 years of experience from the banking and finance sectors as well as from corporate governance and board work in Sweden and Norway. She has served as Senior fund manager and Managing Director at SEB, Nordea Bank, and Odin Funds, and as CEO of NeoNet Securities AB and COO at NeoNet AB, an electronic equity trading platform. In 2002, she also founded the Nordic corporate governance advisory firm Nordic Investor Services AB.

Board member since: 2021

Current assignments:
Board member of:
Stendörren Fastigheter AB (publ.)
Rejlers AB (publ.)
Concordia Maritime AB (publ.)
Lannebo Funds (private)
Factoringgruppen AB (private)

Education:
MBA from the Stockholm School of Economics

Holdings in the company:

Independent in relation to the company/major shareholders: Yes/ Yes

Michel E. Lussier

Michel E. Lussier

Member of the Board

Intro / Experience:
Michel Lussier is a Canadian national and a seasoned Med-tech and Cell Therapy serial entrepreneur with solid expertise in the field of Interventional Cardiology, Congestive Heart Failure Management and Digital Health both in North America and in Europe. He serves as the chairman/cofounder of Celyad SA, a public clinical stage company initially in the field of cell therapy for Congestive Heart Failure and currently Cancer (CAR-T). He has previously worked at Medtronic Inc and Volcano Corp, where he served as Group President. He has also worked at several start-up companies.

Board member since: 2021

Current assignments:
Chairman of Celyad Oncology SA (Euronext & Nasdaq: CYAD)
Chairman of iSTAR Medical SA
Chairman of Gabi Smartcare SA

Education:
Master of Biomedical Engineering (U. of Montreal), MBA (INSEAD)

Holdings in the company:

Independent in relation to the company/major shareholders: Yes/Yes

Tor Peters

Tor Peters

Member of the Board

Intro / Experience:
Tor Peters is a Swedish national with over 30 years of experience in senior positions at various med-tech companies, including BOC Ohmeda, Novo Nordisk, Scimed and Boston Scientific. He is the founder of several med-tech ventures and in 1996 co-founded JOMED, an innovative European interventional cardiology company, achieving the largest global med-tech IPO in 2000.
He joined Occlutech in 2005 and held the position of Group CEO from 2009 to 2017 and Co-CEO from 2018 to 2020.

Board member since: 2009

Current assignments:
Board Member, SIC Invent Switzerland
CEO, Syntach AG, Switzerland
Chairman of the Board, NOLabs AB, Sweden

Education:
BSc from the University of Lund
MBA from IMD in Switzerland

Holdings in the company:
2,980,000 shares

Independent in relation to the company/major shareholders: No/No